PLD
58
2
AAP
26
-7
ADBE
44
3
LYB
44
3
REGN
53
-3
MUR
49
2
EOG
62
6
KO
47
3
FITB
65
2
RHI
40
3
AMT
39
3
EMR
51
-2
NFLX
58
4
TXT
70
-2
KMX
42
2
KR
49
4
MCK
64
2
PNC
59
3
V
40
4
MDLZ
34
4
PLD
58
2
AAP
26
-7
ADBE
44
3
LYB
44
3
REGN
53
-3
MUR
49
2
EOG
62
6
KO
47
3
FITB
65
2
RHI
40
3
AMT
39
3
EMR
51
-2
NFLX
58
4
TXT
70
-2
KMX
42
2
KR
49
4
MCK
64
2
PNC
59
3
V
40
4
MDLZ
34
4
Financhill
Back

Trevi Therapeutics, Inc. 10K Form

Buy
63

TRVI
Trevi Therapeutics, Inc.

Last Price:
$11.93
Seasonality Move:
11.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TRVI News And Ratings

See the #1 stock for the next 7 days that we like better than TRVI

TRVI Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-7.6M
Price / Cash Flow: 0
Annual Sales: $1.43
Price / Book: 8.62

Profitability

EPS (TTM): -0.32080
Net Income (TTM): $-42.8M
Gross Margin: $-132K
Return on Equity: -27.74%
Return on Assets: -26.1%

Trevi Therapeutics, Inc. Earnings Forecast

Key Trevi Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 10 years have been positive in 5 years.

Trevi Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TRVI
CUSIP: 89532M
Website: trevitherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 19.66
Quick Ratio: 19.31

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TRVI Technical Analysis vs Fundamental Analysis

Buy
63
Trevi Therapeutics, Inc. (TRVI) is a Buy

Is Trevi Therapeutics, Inc. a Buy or a Sell?